• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

液相色谱-电喷雾电离离子阱质谱法用于分析大鼠体内和体外东莨菪碱的代谢产物

Liquid chromatography-electrospray ionization ion trap mass spectrometry for analysis of in vivo and in vitro metabolites of scopolamine in rats.

作者信息

Chen Huaixia, Chen Yong, Du Peng, Han Fengmei

机构信息

Ministry-of-Education Key Laboratory for the Synthesis and Application of Organic Functional Molecules & College of Chemistry and Chemical Engineering, Hubei University, Wuhan 430062, China.

出版信息

J Chromatogr Sci. 2008 Jan;46(1):74-80. doi: 10.1093/chromsci/46.1.74.

DOI:10.1093/chromsci/46.1.74
PMID:18218192
Abstract

In vivo and in vitro metabolism of scopolamine is investigated using a highly specific and sensitive liquid chromatography-mass spectrometry (LC-MSn) method. Feces, urine, and plasma samples are collected individually after ingestion of 55 mg/kg scopolamine by healthy rats. Rat feces and urine samples are cleaned up by a liquid-liquid extraction and a solid-phase extraction procedure (C18 cartridges), respectively. Methanol is added to rat plasma samples to precipitate plasma proteins. Scopolamine is incubated with homogenized liver and intestinal flora of rats in vitro, respectively. The metabolites in the incubating solution are extracted with ethyl acetate. Then these pretreated samples are injected into a reversed-phase C18 column with mobile phase of methanol-ammonium acetate (2 mM, adjusted to pH 3.5 with formic acid) (70:30, v/v) and detected by an on-line MSn system. Identification and structural elucidation of the metabolites are performed by comparing their changes in molecular masses (DeltaM), retention-times and full scan MSn spectra with those of the parent drug. The results reveal that at least 8 metabolites (norscopine, scopine, tropic acid, aponorscopolamine, aposcopolamine, norscopolamine, hydroxyscopolamine, and hydroxyscopolamine N-oxide) and the parent drug exist in feces after administering 55 mg/kg scopolamine to healthy rats. Three new metabolites (tetrahydroxyscopolamine, trihydroxy-methoxyscopolamine, and dihydroxy-dimethoxyscopolamine) are identified in rat urine. Seven metabolites (norscopine, scopine, tropic acid, aponorscopolamine, aposcopolamine, norscopolamine, and hydroxyscopolamine) and the parent drug are detected in rat plasma. Only 1 hydrolyzed metabolite (scopine) is found in the rat intestinal flora incubation mixture, and 2 metabolites (aposcopolamine and norscopolamine) are identified in the homogenized liver incubation mixture.

摘要

采用高特异性和高灵敏度的液相色谱-质谱联用(LC-MSn)方法,对东莨菪碱的体内外代谢情况进行了研究。健康大鼠摄入55mg/kg东莨菪碱后,分别收集粪便、尿液和血浆样本。大鼠粪便和尿液样本分别通过液-液萃取和固相萃取程序(C18柱)进行净化处理。向大鼠血浆样本中加入甲醇以沉淀血浆蛋白。东莨菪碱分别与大鼠的肝匀浆和肠道菌群在体外进行孵育。孵育液中的代谢产物用乙酸乙酯萃取。然后将这些预处理后的样本注入反相C18柱,流动相为甲醇-乙酸铵(2mM,用甲酸调至pH 3.5)(70:30,v/v),并通过在线MSn系统进行检测。通过比较代谢产物与母体药物的分子量变化(ΔM)、保留时间和全扫描MSn谱图,对代谢产物进行鉴定和结构解析。结果显示,给健康大鼠施用55mg/kg东莨菪碱后,粪便中至少存在8种代谢产物(去甲东莨菪碱、东莨菪醇、托品酸、阿扑去甲东莨菪碱、阿扑东莨菪碱、去甲东莨菪碱、羟基东莨菪碱和羟基东莨菪碱N-氧化物)以及母体药物。在大鼠尿液中鉴定出3种新的代谢产物(四羟基东莨菪碱、三羟基甲氧基东莨菪碱和二羟基二甲氧基东莨菪碱)。在大鼠血浆中检测到7种代谢产物(去甲东莨菪碱、东莨菪醇、托品酸、阿扑去甲东莨菪碱、阿扑东莨菪碱、去甲东莨菪碱和羟基东莨菪碱)以及母体药物。在大鼠肠道菌群孵育混合物中仅发现1种水解代谢产物(东莨菪醇),在肝匀浆孵育混合物中鉴定出2种代谢产物(阿扑东莨菪碱和去甲东莨菪碱)。

相似文献

1
Liquid chromatography-electrospray ionization ion trap mass spectrometry for analysis of in vivo and in vitro metabolites of scopolamine in rats.液相色谱-电喷雾电离离子阱质谱法用于分析大鼠体内和体外东莨菪碱的代谢产物
J Chromatogr Sci. 2008 Jan;46(1):74-80. doi: 10.1093/chromsci/46.1.74.
2
Analysis of scopolamine and its eighteen metabolites in rat urine by liquid chromatography-tandem mass spectrometry.采用液相色谱-串联质谱法分析大鼠尿液中东莨菪碱及其18种代谢物。
Talanta. 2005 Oct 31;67(5):984-91. doi: 10.1016/j.talanta.2005.04.026.
3
Structural elucidation of in vivo and in vitro metabolites of anisodine by liquid chromatography-tandem mass spectrometry.采用液相色谱-串联质谱法对山莨菪碱体内外代谢产物进行结构解析。
J Pharm Biomed Anal. 2007 Jul 27;44(3):773-8. doi: 10.1016/j.jpba.2007.01.038. Epub 2007 Feb 1.
4
Characterization of metabolites of worenine in rat biological samples using liquid chromatography-tandem mass spectrometry.采用液相色谱-串联质谱法对大鼠生物样品中沃伦宁代谢物进行表征。
J Pharm Biomed Anal. 2010 Jan 5;51(1):236-43. doi: 10.1016/j.jpba.2009.08.026. Epub 2009 Sep 4.
5
Identification of in-vivo and in-vitro metabolites of palmatine by liquid chromatography-tandem mass spectrometry.采用液相色谱-串联质谱法鉴定巴马汀的体内和体外代谢产物。
J Pharm Pharmacol. 2009 May;61(5):647-52. doi: 10.1211/jpp/61.05.0014.
6
[Liquid chromatography-tandem electrospray ionization ion trap mass spectrometric assay for the metabolites of jatrorrhizine in rat urine].[液相色谱-串联电喷雾电离离子阱质谱法测定大鼠尿液中药根碱的代谢产物]
Yao Xue Xue Bao. 2006 Sep;41(9):846-51.
7
Identification of dauricine and its metabolites in rat urine by liquid chromatography-tandem mass spectrometry.采用液相色谱-串联质谱法鉴定大鼠尿液中的蝙蝠葛碱及其代谢产物。
J Chromatogr B Analyt Technol Biomed Life Sci. 2007 Jul 1;854(1-2):1-7. doi: 10.1016/j.jchromb.2007.03.036. Epub 2007 Apr 5.
8
[Analysis of anisodine and its metabolites in rat plasma by liquid chromatography-tandem mass spectrometry].液相色谱-串联质谱法分析大鼠血浆中樟柳碱及其代谢产物
Yao Xue Xue Bao. 2006 Jun;41(6):518-21.
9
LC/MS/MS for identification of in vivo and in vitro metabolites of jatrorrhizine.用于鉴定小檗碱体内和体外代谢产物的液相色谱-串联质谱法。
Biomed Chromatogr. 2008 Dec;22(12):1360-7. doi: 10.1002/bmc.1066.
10
Sensitive and specific liquid chromatographic-tandem mass spectrometric assay for atropine and its eleven metabolites in rat urine.用于测定大鼠尿液中阿托品及其十一种代谢物的灵敏且特异的液相色谱-串联质谱分析法。
J Pharm Biomed Anal. 2006 Jan 23;40(1):142-50. doi: 10.1016/j.jpba.2005.06.027. Epub 2005 Aug 8.

引用本文的文献

1
A Randomized, Crossover, Single-Dose Bioequivalence Study of Two Extended-Release Tablets of Donepezil 23 mg in Healthy Human Volunteers under Fasting and Fed States.一项在健康人类志愿者中进行的,关于23毫克多奈哌齐两种缓释片在禁食和进食状态下的随机、交叉、单剂量生物等效性研究。
Sci Pharm. 2013 Apr 25;81(3):777-91. doi: 10.3797/scipharm.1302-13. Print 2013 Jul-Sep.